Genetic Biomarkers in Hypertrophic Cardiomyopathy

• Maron BJ , GardinJM, FlackJM, GiddingSS, KurosakiTT, BildDE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults.Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults. Circulation92(4), 785–789 (1995).
   PubMed Web of Science ®Google Scholar
• Elliott P , AnderssonB, ArbustiniEet al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur. Heart J. 29(2), 270–276 (2008).
   PubMed Web of Science ®Google Scholar
• Geisterfer-Lowrance AA , KassS, TanigawaGet al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62(5), 999–1006 (1990).
   PubMed Web of Science ®Google Scholar
• Jarcho JA , McKennaW, PareJAet al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N. Engl. J. Med. 321(20), 1372–1378 (1989).
   PubMed Web of Science ®Google Scholar
• Seidman CE , SeidmanJG. Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circulation Res.108(6), 743–750 (2011).
   PubMed Web of Science ®Google Scholar
• Gersh BJ , MaronBJ, BonowROet al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 124(24), e783–e831 (2011).
   PubMed Web of Science ®Google Scholar
• Charron P , AradM, ArbustiniEet al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur. Heart J. 31(22), 2715–2726 (2010).
   PubMed Web of Science ®Google Scholar
• Maron BJ , McKennaWJ, DanielsonGKet al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on clinical expert consensus documents and the European Society of Cardiology Committee for practice guidelines. Eur. Heart J. 24(21), 1965–1991 (2003).
   PubMed Web of Science ®Google Scholar
• Castle WE . Mendel‘s law of heredity. Science18(456), 396–406 (1903).
   PubMedGoogle Scholar
• Brigden W . Uncommon myocardial diseases: the non-coronary cardiomyopathies. Lancet273(7008), 1243–1249 (1957).
   PubMedGoogle Scholar
• Pare JA , FraserRG, PirozynskiWJ, ShanksJA, StubingtonD. Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy. Am. J. Med.31, 37–62 (1961).
   PubMed Web of Science ®Google Scholar
• Donis-Keller H , GreenP, HelmsCet al. A genetic linkage map of the human genome. Cell 51(2), 319–337 (1987).
   PubMed Web of Science ®Google Scholar
• International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature431(7011), 931–945 (2004).
   PubMed Web of Science ®Google Scholar
• Bortot B , AthanasakisE, BrunFet al. High-throughput genotyping robot-assisted method for mutation detection in patients with hypertrophic cardiomyopathy. Diagn. Mol. Pathol. 20(3), 175–179 (2011).
   PubMedGoogle Scholar
• Morita H , RehmHL, MenessesAet al. Shared genetic causes of cardiac hypertrophy in children and adults. N. Engl. J. Med. 358(18), 1899–1908 (2008).
   PubMed Web of Science ®Google Scholar
• Marian AJ , RobertsR. The molecular genetic basis for hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol.33(4), 655–670 (2001).
   PubMed Web of Science ®Google Scholar
• Ho CY , SeidmanCE. A contemporary approach to hypertrophic cardiomyopathy. Circulation113(24), e858–e862 (2006).
   PubMed Web of Science ®Google Scholar
• Keren A , SyrrisP, McKennaWJ. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression. Nat. Clin. Pract. Cardiovasc. Med.5(3), 158–168 (2008).
   PubMedGoogle Scholar
• Watkins H , RosenzweigA, HwangDSet al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326(17), 1108–1114 (1992).
   PubMed Web of Science ®Google Scholar
• Anan R , GreveG, ThierfelderLet al. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J. Clin. Invest. 93(1), 280–285 (1994).
   PubMed Web of Science ®Google Scholar
• Kelly DP , StraussAW. Inherited cardiomyopathies. N. Engl. J. Med.330(13), 913–919 (1994).
   PubMed Web of Science ®Google Scholar
• Ko YL , ChenJJ, TangTKet al. Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg–Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure. Hum. Genet. 97(5), 585–590 (1996).
   PubMed Web of Science ®Google Scholar
• Woo A , RakowskiH, LiewJCet al. Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart 89(10), 1179–1185 (2003).
   PubMed Web of Science ®Google Scholar
• Fananapazir L , EpsteinND. Genotype–phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation89(1), 22–32 (1994).
   PubMed Web of Science ®Google Scholar
• Seidman JG , SeidmanC. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell104(4), 557–567 (2001).
   PubMed Web of Science ®Google Scholar
• Tripathi S , SchultzI, BeckerEet al. Unequal allelic expression of wild-type and mutated beta-myosin in familial hypertrophic cardiomyopathy. Basic Res. Cardiol. 106(6), 1041–1055 (2011).
   PubMed Web of Science ®Google Scholar
• Lowey S , BrettonV, GulickJ, RobbinsJ, TrybusKM. Transgenic mouse alpha- and beta-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences. J. Biol. Chem.288(21), 14780–14787 (2013).
   PubMed Web of Science ®Google Scholar
• Watkins H , ConnerD, ThierfelderLet al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat. Genet. 11(4), 434–437 (1995).
   PubMed Web of Science ®Google Scholar
• Niimura H , BachinskiLL, SangwatanarojSet al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med. 338(18), 1248–1257 (1998).
   PubMed Web of Science ®Google Scholar
• Charron P , DubourgO, DesnosMet al. Genotype–phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur. Heart J. 19(1), 139–145 (1998).
   PubMed Web of Science ®Google Scholar
• Niimura H , PattonKK, McKennaWJet al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105(4), 446–451 (2002).
   PubMed Web of Science ®Google Scholar
• Christiaans I , BirnieE, van LangenIMet al. The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. Eur. Heart J. 31(7), 842–848 (2010).
   PubMed Web of Science ®Google Scholar
• Teirlinck CH , SenniF, MaltiREet al. A human MYBPC3 mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death. BMC Med. Genet. 13, 105 (2012).
   PubMed Web of Science ®Google Scholar
• Moolman-Smook JC , de LangeWJ, BruwerEC, BrinkPA, CorfieldVA. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am. J. Hum. Genet. 65(5), 1308–1320 (1999).
   PubMed Web of Science ®Google Scholar
• Kaski JP , SyrrisP, EstebanMTet al. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ. Cardiovasc. Genet. 2(5), 436–441 (2009).
   PubMedGoogle Scholar
• Page SP , KounasS, SyrrisPet al. Cardiac myosin binding protein C mutations in families with hypertrophic cardiomyopathy: disease expression in relation to age, gender, and long term outcome. Circ. Cardiovasc. Genet. 5(2), 156–166 (2012).
   PubMedGoogle Scholar
• Marston S , CopelandO, JacquesAet al. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circulation Res. 105(3), 219–222 (2009).
   PubMed Web of Science ®Google Scholar
• van Dijk SJ , DooijesD, Dos RemediosCet al. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 119(11), 1473–1483 (2009).
   PubMed Web of Science ®Google Scholar
• Marston S , CopelandO, GehmlichK, SchlossarekS, CarrierL. How do MYBPC3 mutations cause hypertrophic cardiomyopathy?J. Muscle Res. Cell Motil.33(1), 75–80 (2012).
   PubMed Web of Science ®Google Scholar
• Thierfelder L , WatkinsH, MacraeCet al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77(5), 701–712 (1994).
   PubMed Web of Science ®Google Scholar
• Watkins H , McKennaWJ, ThierfelderLet al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med. 332(16), 1058–1064 (1995).
   PubMed Web of Science ®Google Scholar
• Pasquale F , SyrrisP, KaskiJP, MogensenJ, McKennaWJ, ElliottP. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene. Circ. Cardiovasc. Genet.5(1), 10–17 (2012).
   PubMedGoogle Scholar
• Varnava AM , ElliottPM, BaboonianC, DavisonF, DaviesMJ, McKennaWJ. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation104(12), 1380–1384 (2001).
   PubMed Web of Science ®Google Scholar
• Manning EP , TardiffJC, SchwartzSD. Molecular effects of familial hypertrophic cardiomyopathy-related mutations in the TNT1 domain of cTnT. J. Mol. Biol.421(1), 54–66 (2012).
   PubMed Web of Science ®Google Scholar
• Kimura A , HaradaH, ParkJEet al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16(4), 379–382 (1997).
   PubMed Web of Science ®Google Scholar
• Mogensen J , MurphyRT, KuboTet al. Frequency and clinical expression of cardiac troponin I mutations in 748 consecutive families with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44(12), 2315–2325 (2004).
   PubMed Web of Science ®Google Scholar
• Willott RH , GomesAV, ChangAN, ParvatiyarMS, PintoJR, PotterJD. Mutations in troponin that cause HCM, DCM and RCM: what can we learn about thin filament function?J. Mol. Cell. Cardiol.48(5), 882–892 (2010).
   PubMed Web of Science ®Google Scholar
• Watkins H , AnanR, CovielloDA, SpiritoP, SeidmanJG, SeidmanCE. A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy. Circulation91(9), 2302–2305 (1995).
   PubMed Web of Science ®Google Scholar
• Poetter K , JiangH, HassanzadehSet al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13(1), 63–69 (1996).
   PubMed Web of Science ®Google Scholar
• Kabaeva ZT , PerrotA, WolterBet al. Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur. J. Hum. Genet. 10(11), 741–748 (2002).
   PubMed Web of Science ®Google Scholar
• Mogensen J , KlausenIC, PedersenAKet al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J. Clin. Invest. 103(10), R39–R43 (1999).
   PubMed Web of Science ®Google Scholar
• Olson TM , MichelsVV, ThibodeauSN, TaiYS, KeatingMT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science280(5364), 750–752 (1998).
   PubMed Web of Science ®Google Scholar
• Landstrom AP , ParvatiyarMS, PintoJRet al. Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J. Mol. Cell. Cardiol. 45(2), 281–288 (2008).
   PubMed Web of Science ®Google Scholar
• Geier C , PerrotA, OzcelikCet al. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107(10), 1390–1395 (2003).
   PubMed Web of Science ®Google Scholar
• Vasile VC , WillML, OmmenSR, EdwardsWD, OlsonTM, AckermanMJ. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol. Genet. Metab.87(2), 169–174 (2006).
   PubMed Web of Science ®Google Scholar
• Osio A , TanL, ChenSNet al. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circulation Res. 100(6), 766–768 (2007).
   PubMed Web of Science ®Google Scholar
• Carniel E , TaylorMR, SinagraGet al. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 112(1), 54–59 (2005).
   PubMed Web of Science ®Google Scholar
• Wang H , LiZ, WangJet al. Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy. Am. J. Hum. Genet. 87(5), 687–693 (2010).
   PubMed Web of Science ®Google Scholar
• Landstrom AP , WeislederN, BataldenKBet al. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J. Mol. Cell. Cardiol. 42(6), 1026–1035 (2007).
   PubMed Web of Science ®Google Scholar
• Minamisawa S , SatoY, TatsuguchiYet al. Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 304(1), 1–4 (2003).
   PubMed Web of Science ®Google Scholar
• Chiu C , TeboM, InglesJet al. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. J. Mol. Cell. Cardiol. 43(3), 337–343 (2007).
   PubMed Web of Science ®Google Scholar
• Wicks EC , ElliottPM. Genetics and metabolic cardiomyopathies. Herz37(6), 598–610 (2012).
   PubMed Web of Science ®Google Scholar
• Arad M , MaronBJ, GorhamJMet al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 352(4), 362–372 (2005).
   PubMed Web of Science ®Google Scholar
• Rapezzi C , ArbustiniE, CaforioALet al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 34(19), 1448–1458 (2013).
   PubMed Web of Science ®Google Scholar
• Elliott P , BakerR, PasqualeFet al. Prevalence of Anderson–Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson–Fabry disease survey. Heart 97(23), 1957–1960 (2011).
   PubMed Web of Science ®Google Scholar
• Meikle PJ , HopwoodJJ, ClagueAE, CareyWF. Prevalence of lysosomal storage disorders. JAMA281(3), 249–254 (1999).
   PubMed Web of Science ®Google Scholar
• Chimenti C , PieroniM, MorganteEet al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 110(9), 1047–1053 (2004).
   PubMed Web of Science ®Google Scholar
• Rohrbach M , ClarkeJT. Treatment of lysosomal storage disorders:progress with enzyme replacement therapy. Drugs67(18), 2697–2716 (2007).
   PubMed Web of Science ®Google Scholar
• Koopman WJ , WillemsPH, SmeitinkJA. Monogenic mitochondrial disorders. N. Engl. J. Med.366(12), 1132–1141 (2012).
   PubMed Web of Science ®Google Scholar
• Aoki Y , NiihoriT, KawameHet al. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet. 37(10), 1038–1040 (2005).
   PubMed Web of Science ®Google Scholar
• Sarkozy A , ContiE, SeripaDet al. Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J. Med. Genet. 40(9), 704–708 (2003).
   PubMed Web of Science ®Google Scholar
• Sharland M , BurchM, McKennaWM, PatonMA. A clinical study of Noonan syndrome. Arch. Dis. Child.67(2), 178–183 (1992).
   PubMed Web of Science ®Google Scholar
• Sala V , GalloS, LeoC, GattiS, GelbBD, CrepaldiT. Signaling to cardiac hypertrophy: insights from human and mouse RASopathies. Mol. Med.18, 938–947 (2012).
   PubMed Web of Science ®Google Scholar
• Gueneau L , BertrandAT, JaisJPet al. Mutations of the FHL1 gene cause Emery–Dreifuss muscular dystrophy. Am. J. Hum. Genet. 85(3), 338–353 (2009).
   PubMed Web of Science ®Google Scholar
• Vicart P , DupretJM, HazanJet al. Human desmin gene: cDNA sequence, regional localization and exclusion of the locus in a familial desmin-related myopathy. Hum. Genet. 98(4), 422–429 (1996).
   PubMed Web of Science ®Google Scholar
• Stoeckel ME , OsbornM, PorteA, SacrezA, BatzenschlagerA, WeberK. An unusual familial cardiomyopathy characterized by aberrant accumulations of desmin-type intermediate filaments. Virchows Arch. A Pathol. Anat. Histol.393(1), 53–60 (1981).
   PubMed Web of Science ®Google Scholar
• Armel TZ , LeinwandLA. Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc. Natl Acad. Sci USA106(15), 6291–6296 (2009).
   PubMed Web of Science ®Google Scholar
• Laing NG , LaingBA, MeredithCet al. Autosomal dominant distal myopathy: linkage to chromosome 14. Am. J. Hum. Genet. 56(2), 422–427 (1995).
   PubMed Web of Science ®Google Scholar
• Dubrey SW , HawkinsPN, FalkRH. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart97(1), 75–84 (2011).
   PubMed Web of Science ®Google Scholar
• Lachmann HJ , BoothDR, BoothSEet al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N. Engl. J. Med. 346(23), 1786–1791 (2002).
   PubMed Web of Science ®Google Scholar
• Jacobson DR , PastoreRD, YaghoubianRet al. Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. N. Engl. J. Med. 336(7), 466–473 (1997).
   PubMed Web of Science ®Google Scholar
• Banypersad SM , MoonJC, WhelanC, HawkinsPN, WechalekarAD. Updates in cardiac amyloidosis: a review. J. Am Heart Assoc.1(2), e000364 (2012).
   PubMed Web of Science ®Google Scholar
• Dungu JN , AndersonLJ, WhelanCJ, HawkinsPN. Cardiac transthyretin amyloidosis. Heart98(21), 1546–1554 (2012).
   PubMed Web of Science ®Google Scholar
• Baccouche H , MaunzM, BeckTet al. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography 29(6), 668–677 (2012).
   PubMed Web of Science ®Google Scholar
• Sado DM , FlettAS, BanypersadSMet al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98(19), 1436–1441 (2012).
   PubMed Web of Science ®Google Scholar
• Sharma S , MaronBJ, WhyteG, FirooziS, ElliottPM, McKennaWJ. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athlete‘s heart and hypertrophic cardiomyopathy. J. Am. Coll. Cardiol.40(8), 1431–1436 (2002).
   PubMed Web of Science ®Google Scholar
• Basavarajaiah S , BoraitaA, WhyteGet al. Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 51(23), 2256–2262 (2008).
   PubMed Web of Science ®Google Scholar
• Olivotto I , CecchiF, PoggesiC, YacoubMH. Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis. Nat. Rev. Cardiol.6(4), 317–321 (2009).
   PubMed Web of Science ®Google Scholar
• Ashrafian H , RedwoodC, BlairE, WatkinsH. Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet.19(5), 263–268 (2003).
   PubMed Web of Science ®Google Scholar
• Olivotto I , MaronMS, AdabagASet al. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 46(3), 480–487 (2005).
   PubMed Web of Science ®Google Scholar
• Jensen MK , HavndrupO, ChristiansenMet al. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12 year follow-up study of clinical screening and predictive genetic testing. Circulation 127(1), 48–54 (2013).
   PubMed Web of Science ®Google Scholar
• Van Driest SL , VasileVC, OmmenSRet al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44(9), 1903–1910 (2004).
   PubMed Web of Science ®Google Scholar
• Ingles J , DoolanA, ChiuC, SeidmanJ, SeidmanC, SemsarianC. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J. Med. Genet.42(10), e59 (2005).
   PubMed Web of Science ®Google Scholar
• Lopes LR , ZekavatiA, SyrrisPet al. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J. Med. Genet. 50(4), 228–239 (2013).
   PubMed Web of Science ®Google Scholar
• Watkins H . Assigning a causal role to genetic variants in hypertrophic cardiomyopathy. Circ. Cardiovasc. Genet.6(1), 2–4 (2013).
   PubMedGoogle Scholar
• Fahrner JA , MurphyAM, Gunay-AygunM. Hypertrophic cardiomyopathy: how far should we go with genetic testing?Am. J. Med. Genet. A161A(1), 232–233 (2013).
   PubMed Web of Science ®Google Scholar
• Shah S , NelsonCP, GauntTRet al. Four genetic loci influencing electrocardiographic indices of left ventricular hypertrophy. Circ. Cardiovasc. Genet. 4(6), 626–635 (2011).
   PubMedGoogle Scholar
• Hong KW , ShinDJ, LeeSHet al. Common variants in RYR1 are associated with left ventricular hypertrophy assessed by electrocardiogram. Eur. Heart J. 33(10), 1250–1256 (2012).
   PubMed Web of Science ®Google Scholar
• Perkins MJ , Van DriestSL, EllsworthEGet al. Gene-specific modifying effects of pro-LVH polymorphisms involving the rennin–angiotensin–aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy. Eur. Heart J. 26(22), 2457–2462 (2005).
   PubMed Web of Science ®Google Scholar
• Lechin M , QuinonesMA, OmranAet al. Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 92(7), 1808–1812 (1995).
   PubMed Web of Science ®Google Scholar
• Kaufman BD , AuerbachS, ReddySet al. RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy. Hum. Genet.122(5), 515–523 (2007).
   PubMed Web of Science ®Google Scholar
• Hwang JJ , AllenPD, TsengGCet al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol. Genomics 10(1), 31–44 (2002).
   PubMed Web of Science ®Google Scholar
• Rajan S , WilliamsSS, JagatheesanGet al. Microarray analysis of gene expression during early stages of mild and severe cardiac hypertrophy. Physiol. Genomics 27(3), 309–317 (2006).
   PubMed Web of Science ®Google Scholar
• Ivandic BT , MastitskySE, SchonsiegelFet al. Whole-genome analysis of gene expression associates the ubiquitin–proteasome system with the cardiomyopathy phenotype in disease-sensitized congenic mouse strains. Cardiovasc. Res. 94(1), 87–95 (2012).
   PubMed Web of Science ®Google Scholar
• Konhilas JP , WatsonPA, MaassAet al. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circulation Res. 98(4), 540–548 (2006).
   PubMed Web of Science ®Google Scholar
• Hatcher CJ , BassonCT. Taking a bite out of hypertrophic cardiomyopathy: soy diet and disease. J. Clin. Invest.116(1), 16–19 (2006).
   PubMed Web of Science ®Google Scholar
• Gruner C , IvanovJ, CareMet al. Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ. Cardiovasc. Genet. 6(1), 19–26 (2013).
   PubMed Web of Science ®Google Scholar
• Van Driest SL , MaronBJ, AckermanMJ. From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy. Heart90(1), 7–8 (2004).
   PubMed Web of Science ®Google Scholar
• Charron P . Genetic analysis for predictive screening in hypertrophic cardiomyopathy. Heart98(8), 603–604 (2012).
   PubMed Web of Science ®Google Scholar
• Ho CY . Genetic considerations in hypertrophic cardiomyopathy. Prog. Cardiovasc. Dis.54(6), 456–460 (2012).
   PubMed Web of Science ®Google Scholar
• Bratt EL , Ostman-SmithI, Sparud-LundinC, AxelssonBA. Parents‘ experiences of having an asymptomatic child diagnosed with hypertrophic cardiomyopathy through family screening. Cardiol. Young21(1), 8–14 (2011).
   PubMed Web of Science ®Google Scholar
• Ross LF , SaalHM, DavidKLet al. Ethical and policy issues in genetic testing and screening of children. Pediatrics 131(3), 620–622 (2013).
   PubMed Web of Science ®Google Scholar
• Cambronero F , MarinF, RoldanV, Hernandez-RomeroD, ValdesM, LipGY. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur. Heart J.30(2), 139–151 (2009).
   PubMed Web of Science ®Google Scholar
• Kubo T , KitaokaH, OkawaMet al. Combined measurements of cardiac troponin I and brain natriuretic peptide are useful for predicting adverse outcomes in hypertrophic cardiomyopathy. Circ. J. 75(4), 919–926 (2011).
   PubMed Web of Science ®Google Scholar
• Coats CJ , GallagherMJ, FoleyMet al. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. Eur. Heart J. doi:10.1093/eurheartj/eht070 (2013) (Epub ahead of print).
   Google Scholar
• Ho CY , LopezB, Coelho-FilhoORet al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N. Engl. J. Med. 363(6), 552–563 (2010).
   PubMed Web of Science ®Google Scholar
• Ho CY , AbbasiSA, NeilanTGet al. T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy. Circ. Cardiovasc. Imaging 6(3), 415–422 (2013).
   PubMed Web of Science ®Google Scholar
• Chiu C , TeboM, InglesJet al. Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. J. Mol. Cell Cardiol. 43(3), 337–343 (2007).
   PubMed Web of Science ®Google Scholar
• Hayashi T , ArimuraT, Itoh-SatohM et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol.44(11), 2192–2201 (2004).
   PubMed Web of Science ®Google Scholar
• Chiu C , BagnallRD, InglesJet al. Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. J. Am. Coll. Cardiol. 55(11), 1127–1135 (2010).
   PubMed Web of Science ®Google Scholar

▪ Website

• Online Mendelian Inheritance in Man, OMIM® (2013). www.omim.org
   Google Scholar